In a first for China, Neuracle’s implantable brain-computer interface wins approval

2026-03-13 - 09:35

In a landmark development, Neuracle Medical Technology has secured the country’s first-ever approval for an implantable brain-computer interface (BCI) system designed to restore hand motor function in patients with spinal cord injuries, in a regulatory milestone that underscores China’s accelerating push in neurotechnology. China’s BCI start-ups, seen as potential rivals to Elon Musk’s Neuralink, are gaining momentum as regulatory support and fresh capital fuel growth. Shares of BCI companies...